In Season 2 of The Road to a Vaccine, host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.
Live
Live at 12 PM ET on Tuesdays
Tune in on JNJ.com, Facebook, LinkedIn or Twitter. Come back to this page at any time to watch a replay.
Season 2, Episode 7
Is It Really Safe for Schools to Be Open Right Now?
As schools reopen—and sometimes close again—what have we learned about the risks of in-person learning? Lisa Ling speaks to school nurse Robin Cogan and pediatrician Dr. Sam Maldonado to find answers and debunk myths around kids and COVID-19.

Season 2 Episodes

    Season 2, Episode 1
    July 07, 2020
    In the Season 2 premiere, Lisa Ling checks into the virtual AIDS 2020 conference to talk with actress and HIV advocate Laverne Cox, Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., and others about the ongoing quest for an HIV vaccine and how that’s informing research on COVID-19 vaccines.
    How Lessons Learned in Fighting HIV Help Us Battle COVID-19
    How Lessons Learned in Fighting HIV Help Us Battle COVID-19
    Season 2, Episode 2
    July 14, 2020
    Lisa Ling talks with Dr. Francis Collins, Director, NIH, about the latest on treatments and vaccines. Also, Harvard's Dr. Ashish Jha shares how the virus affects the body and Johns Hopkins' Dr. Tom Inglesby explains what the new data on spread means for people.
    How New COVID-19 Outbreaks Are Impacting a Global Return to Normal
    How New COVID-19 Outbreaks Are Impacting a Global Return to Normal
    Season 2, Episode 3
    July 21, 2020
    Lisa Ling talks to UNICEF’s Henrietta Fore about global efforts to get all kids vaccinated. Harvard's Dr. Vikram Patel discusses children’s mental health during the pandemic. Plus, parents ask the experts their pressing questions about COVID-19.
    How is COVID-19 Affecting Children? What Parents Worldwide Should Know
    How is COVID-19 Affecting Children? What Parents Worldwide Should Know
    Season 2 Special
    July 28, 2020
    In this bonus clip from “The Road to a Vaccine,” global public health experts weigh the risks—and benefits—of sending kids back to the classroom. Plus, the one frequently forgotten group that must be included in all decisions. Be sure to tune in for the next live episode of “The Road to a Vaccine, which returns August 18 at 12:00 PM ET.
    Hear from the Experts: Is it Safe to Send Kids Back to School This Fall?
    Hear from the Experts: Is it Safe to Send Kids Back to School This Fall?
    Season 2 Special
    August 06, 2020
    In this Vaccines 101 bonus clip from “The Road to a Vaccine,” experts explain what happens during vaccine clinical trials and why these steps are crucial to ensuring vaccines are not just safe, but also effective. Also, be sure to tune in for the next live episode of “The Road to a Vaccine," which returns August 18 at 12:00 PM ET.
    Vaccines 101: How Do Clinical Vaccine Trials Work?
    Vaccines 101: How Do Clinical Vaccine Trials Work?
    Season 2 Special
    August 11, 2020
    In this bonus clip from “The Road to a Vaccine,” Thrive Global's Arianna Huffington and others discuss the pressures on frontline healthcare workers that come with battling this pandemic. Also, doctors and nurses themselves share some of the rewarding moments they’ve had while working to save lives. Be sure to tune in for the next live episode of “The Road to a Vaccine," which returns August 18 at 12:00 PM ET.
    How Is COVID-19 Affecting Frontline Healthcare Workers and Their Families?
    How Is COVID-19 Affecting Frontline Healthcare Workers and Their Families?
    Season 2, Episode 4
    August 18, 2020
    In this week’s episode of “The Road to a Vaccine,” Lisa Ling talks with scientific journalists, healthcare experts and others about the role of social movements—both in the past and today with the COVID-19 pandemic—in driving access to care, building critical disease awareness and more. Guests include journalist David France, Dr. Sudip Parikh, CEO of the American Association for the Advancement of Science, Mary Woolley, President and CEO of grassroots health organization Research!America and Seema Kumar, Vice President, Innovation, Global Health and Science Policy Communication at Johnson & Johnson.
    How Healthcare Advocates Are Changing the Global Conversation about COVID-19
    How Healthcare Advocates Are Changing the Global Conversation about COVID-19
    Season 2 Special
    August 25, 2020
    Why Racial Disparities in Healthcare Make COVID-19’s Impact Worse for Minorities | Johnson & Johnson
    Why Racial Disparities in Healthcare Make COVID-19’s Impact Worse for Minorities | Johnson & Johnson
    Season 2 Special
    September 01, 2020
    Why Trusting Science Right Now is More Important Than Ever
    Why Trusting Science Right Now is More Important Than Ever
    Season 2, Episode 5
    September 08, 2020
    Lisa Ling asks health experts for a pandemic status report, including the latest statistics on cases worldwide, the current thinking about coronavirus and its effects and what’s working to fight the disease—and what’s not.
    What Have We Learned After Eight Months of COVID-19?
    What Have We Learned After Eight Months of COVID-19?
    Season 2, Episode 6
    September 15, 2020
    As we head into fall, how is COVID-19 testing going? Lisa Ling speaks to experts, including Ann Lee, co-founder, with actor Sean Penn, of the nonprofit CORE, to get the latest updates on testing efforts and contact tracing across America.
    Everything You Need to Know about COVID-19 Testing and Contact Tracing
    Everything You Need to Know about COVID-19 Testing and Contact Tracing
Meet Our Host
Ling is the Executive Producer and host of This Is Life on CNN. She has also been a field correspondent for The Oprah Winfrey Show and a contributor to ABC News' Nightline.
School nurse Robin Cogan
Season 2, Episode 7: Expert Guest
Robin Cogan
Robin Cogan
Cogan is a nationally certified school nurse in her 20th year serving the students and families of Camden, New Jersey. She is a blogger, gun violence prevention activist and has been nationally recognized for her work in school nursing and population health. Most recently, she was the recipient of the 2020 National Association of School Nurses President's Award.
Season 2, Episode 7: J&J Expert Guest
Sam Maldonado, M.D., M.P.H., FAAP
Sam Maldonado, M.D., M.P.H., FAAP
Dr. Maldonado is a pediatric infectious diseases physician and Vice President of Pediatric Drug Development at Janssen Research & Development. For the past two decades, Dr. Maldonado has worked in developing new medicines for children. He was a Medical Officer at the U.S. Food and Drug Administration (FDA) in the 1990s during the HIV/AIDS pandemic. While working in the Antiviral Division at the FDA, Dr. Maldonado also worked on policy issues that culminated with the pediatric laws that govern pediatric drug development today.
Season 2, Episode 7: Expert Guest
Cindi Leive
Cindi Leive
Leive is an award-winning journalist, media leader and advocate for women. She is the former editor-in-chief of both Glamour and Self magazines; the force behind barrier-breaking initiatives like Glamour Women of the Year; and the author or producer of numerous best-selling books including Together We Rise, about the making of the Women's March. She is currently a senior fellow at the University of Southern California’s Annenberg Center.
Season 2, Episode 7: Expert Guest
Lucy Bernstein
Lucy Bernstein
Bernstein, 17, is a freshman at the University of Michigan.
On the next episode of "The Road to a Vaccine," host Lisa Ling delves into how the pandemic is affecting parents, children and school staff. We sat down with one of the upcoming guests, school nurse Robin Cogan, to find out the most pressing questions on her mind—and those of moms and dads.

Season 1 Episodes

    Season 1, Episode 1
    April 14, 2020
    Join host Lisa Ling as she interviews scientists and healthcare workers about how vaccines work, the impact of the COVID-19 pandemic and what’s being done globally to create a novel coronavirus vaccine.
    How a COVID-19 Vaccine Might Work. Plus, How Quickly We Could Get There
    How a COVID-19 Vaccine Might Work. Plus, How Quickly We Could Get There
    Season 1, Episode 2
    April 21, 2020
    Three leading scientists who have been on the frontlines of Zika, malaria and HIV give you the inside scoop on vaccine development and the process of going from lab to clinic.
    What it Takes to Create a Coronavirus Vaccine in Record Time
    What it Takes to Create a Coronavirus Vaccine in Record Time
    Season 1, Episode 3
    April 28, 2020
    Lisa Ling interviews National Academies member and University Professor at the University of Connecticut, Cato Laurencin, M.D., Ph.D., to learn what his new coronavirus study reveals. Plus, what’s needed to mass-produce a vaccine and what we’ve learned from other outbreaks.
    Why is COVID-19 Hitting Minority Communities So Hard?
    Why is COVID-19 Hitting Minority Communities So Hard?
    Season 1, Episode 4
    May 05, 2020
    This week we hear from two ER doctors about what they’ve learned from caring for COVID-19 patients. A renowned epidemiologist shares why testing is so important. A Nigerian doctor who recovered from Ebola herself talks about how fighting this outbreak is different. Plus, a leading scientist talks about how long vaccine immunity could last.
    What Doctors On The Front Lines of COVID-19 Are Now Saying About the Virus
    What Doctors On The Front Lines of COVID-19 Are Now Saying About the Virus
    Season 1, Episode 5
    May 12, 2020
    Two nurses—one on the front lines in the ICU, and one leading the charge to advocate for her profession—talk about what caring for patients, and each other, really means right now. An activist talks about recovering from the virus and a scientist shares the challenges of creating a vaccine for clinical. Plus, Arianna Huffington and Husseini K. Manji, MD, FRCPC, discuss the other COVID-19 crisis: how it's impacting mental health.
    How Nurses Are Battling the COVID-19 Pandemic
    How Nurses Are Battling the COVID-19 Pandemic
    Season 1, Episode 6
    May 19, 2020
    In Episode 6, Ling talks with Jane Halton, Chair of the Coalition for Epidemic Preparedness Innovations, about her work to ensure people globally get access to vaccines. Seema Kumar, Vice President, Innovation, Global Health and Science Policy Communication, discusses the challenges of fighting the pandemic. Plus, Janssen supply chain expert Remo Colarusso explains what it takes to get vaccines from the lab and into health workers' hands, and Laura Lane, President of Global Public Affairs at UPS, talks about the logistics of shipping during a pandemic. We also hear from youth advocate Adefare Tomisin Elizabeth on how she's educating people about the virus in remote areas of Nigeria.
    How the Global Community is Coming Together to Battle COVID-19
    How the Global Community is Coming Together to Battle COVID-19
    Season 1, Episode 7
    May 26, 2020
    In Episode 7, Lisa Ling speaks with Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., about important advances being made in vaccine development. Former FDA Commissioner Mark McClellan, M.D., Ph.D., discusses what reopening could look like and global health leader Jonathan Quick, M.D., MPH, shares why he believes testing is critical to help manage this pandemic.
    What Our “New Normal” Might Look Like Until We Get a COVID-19 Vaccine
    What Our “New Normal” Might Look Like Until We Get a COVID-19 Vaccine
    Season 1, Episode 8
    June 02, 2020
    In the season finale of The Road to a Vaccine, pandemic pioneers Paul Stoffels, M.D., and Peter Piot, M.D., Ph.D., discuss Dr. Piot’s own experience battling COVID-19. Cato Laurencin, M.D., Ph.D., a world-renowned physician and healthcare leader weighs in on how racism is a public health crisis and discusses the impact of recent protests in the midst of a pandemic. Plus, Lisa Ling talks with International Rescue Committee President and CEO Rt Hon David Miliband about how to protect refugees and other groups particularly vulnerable to the effects of the novel coronavirus.
  • What People Are Saying

      Amazing & great explanation of the development of a vaccine in a succinct way. Many thanks, Dr. Mathai.

      Excellent interview! Dr. Stoffels = Terrific!

      Amazing job from Laverne Cox and a big THANK YOU for sharing your knowledge and experienced perspective! I happily watched the number of viewers rise.

      Excellent speakers. It gives a good perspective on what the nurses are dealing with. Thank you!

      Such an awesome episode!! Great panelists!!! Happy Nurses day to all nurses, especially my sister!!!

      Glad to see how leaders from J&J are supporting front liners, which is an incredible example of serving community as a first priority. Many thanks.

      Wonderful guests—thank you!

      Thank you Lisa for doing these interviews and the J&J team for providing this information. Your calm, thoughtful approach to covering these complex multi-dimensional issues is so appreciated.🌼

      Best wishes, Dr. Schuitemaker. Thanks for all the hard work, conducting number of trial activities in parallel and collaborating across the industry.

      Appreciate all the hard work of our scientists, sacrificing so much of their time. You guys are heroes!

      Amazing, we value your countless contributions to saving lives.

      Looking forward to tuning in to tomorrow's episode. Appreciate these very informative sessions. Thanks, Lisa!

      It is really brilliant to see that Johnson and Johnson are gearing up for production worldwide for the vaccines once approved by PHE.

      I love my company, worked a lot of years being an inspector. Miss not working, I'm retired now. They will find a vaccine.

      The Human Genome Project began with the same spirit. Well done J&J for reviving that collaborative working.

  • Submit a Question
    Do you have a question that you would like to have answered on an upcoming episode of The Road to a Vaccine?
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue